Serum claudin-5, claudin-11, occludin, vinculin, paxillin, and beta-catenin levels in preschool children with autism spectrum disorder

References

• Esnafoglu E, Cırrık S, Ayyıldız SN, et al. Increased serum zonulin levels as an ıntestinal permeability marker in autistic subjects. J Pediatr. 2017;188:240–244.
   PubMed Web of Science ®Google Scholar
• Karagözlü S, Dalgıç B, İşeri E. The relationship of severity of autism with gastrointestinal symptoms and serum zonulin levels in autistic children. J Autism Dev Disord. 2022;52(2):623–629.
   PubMed Web of Science ®Google Scholar
• Kumar H, Sharma B. Minocycline ameliorates prenatal valproic acid induced autistic behaviour, biochemistry and blood brain barrier impairments in rats. Brain Res. 2016;1630:83–97.
   PubMed Web of Science ®Google Scholar
• Cascio L, Chen C, Pauly R, et al. Abnormalities in the genes that encode large amino acid transporters increase the risk of autism spectrum disorder. Molec Gen & Gen Med. 2020;8(1):e1036.
   PubMed Web of Science ®Google Scholar
• Coll-Tané M, Gong NN, Belfer SJ, et al. The CHD8/CHD7/kismet family links blood-brain barrier glia and serotonin to ASD-associated sleep defects. Sci Adv. 2021;7(23):eabe2626.
   PubMed Web of Science ®Google Scholar
• Bashir S, Al-Ayadhi L. Endothelial antibody levels in the sera of children with autism spectrum disorders. J Chin Med Assoc. 2015;78(7):414–417.
   PubMed Web of Science ®Google Scholar
• Ayaydın H, Kirmit A, Çelik H, et al. High serum levels of serum 100 beta protein, neuron-specific enolase, tau, active caspase-3, M30 and M65 in children with autism spectrum disorders. Clin Psychopharmacol Neurosci. 2020;18(2):270–278.
   PubMedGoogle Scholar
• Kameno Y, Iwata K, Matsuzaki H, et al. Serum levels of soluble platelet endothelial cell adhesion molecule-1 and vascular cell adhesion molecule-1 are decreased in subjects with autism spectrum disorder. Mol Autism. 2013;4(1):19.
   PubMedGoogle Scholar
• Lv M, Zhang H, Shu Y, et al. The neonatal levels of TSB, NSE and CK-BB in autism spectrum disorder from Southern China. Transl Neurosci. 2016;7(1):6–11.
   PubMed Web of Science ®Google Scholar
• Zheng Z, Zheng P, Zou X. Peripheral blood S100B levels in autism spectrum disorder: a systematic review and Meta-Analysis. J Autism Dev Disord. 2021;51(8):2569–2577.
   PubMed Web of Science ®Google Scholar
• Deckmann I, Santos‐Terra J, Fontes‐Dutra M, et al. Resveratrol prevents brain edema, blood–brain barrier permeability, and altered aquaporin profile in autism animal model. Int J Dev Neurosci. 2021;81(7):579–604.
   PubMed Web of Science ®Google Scholar
• O’Roak BJ, Vives L, Fu W, et al. Multiplex targeted sequencing ıdentifies recurrently mutated genes in autism spectrum disorders. Science (80-). 2012;338(6114):1619–1622.
   PubMed Web of Science ®Google Scholar
• Chelakkot C, Ghim J, Ryu SH. Mechanisms regulating intestinal barrier integrity and its pathological implications. Exp Mol Med. 2018;50(8):1–9.
   PubMed Web of Science ®Google Scholar
• Kara H, Acikel SB, Cetinkaya M, et al. Serum zonulin levels are higher Among children with autism spectrum disorders and correlated with social ımpairment. Alpha Psychiatry. 2021;22(5):250–256.
   PubMedGoogle Scholar
• Kartalcı G, Çalışkan Demir A, Kartalcı Ş, et al. Evaluation of blood zonulin levels, ınflammatory processes adn neuronal changes in children With autism spectrum disorder. Psychiatr Danub. 2022;34(2):279–287.
   PubMed Web of Science ®Google Scholar
• Fiorentino M, Sapone A, Senger S, et al. Blood–brain barrier and intestinal epithelial barrier alterations in autism spectrum disorders. Mol Autism. 2016;7(1):49.
   PubMedGoogle Scholar
• de Magistris L, Familiari V, Pascotto A, et al. Alterations of the intestinal barrier in patients with autism spectrum disorders and in their first-degree relatives. J Pediatr Gastroenterol Nutr. 2010;51(4):418–424.
   PubMed Web of Science ®Google Scholar
• Kushak RI, Buie TM, Murray KF, et al. Evaluation of ıntestinal function in children With autism and gastrointestinal symptoms. J Pediatr Gastroenterol Nutr. 2016;62(5):687–691.
   PubMed Web of Science ®Google Scholar
• Keaney J, Campbell M. The dynamic blood-brain barrier. Febs J. 2015;282(21):4067–4079.
   PubMed Web of Science ®Google Scholar
• Aydoğan Avşar P, Işık Ü, Aktepe E, et al. Serum zonulin and claudin-5 levels in children with attention-deficit/hyperactivity disorder. Int J Psychiatry Clin Pract. 2021;25(1):49–55.
   PubMed Web of Science ®Google Scholar
• Kılıç F, Işık Ü, Demirdaş A, et al. Serum zonulin and claudin-5 levels in patients with bipolar disorder. J Affect Disord. 2020;266:37–42.
   PubMed Web of Science ®Google Scholar
• Usta A, Kılıç F, Demirdaş A, et al. Serum zonulin and claudin-5 levels in patients with schizophrenia. Eur Arch Psychiatry Clin Neurosci. 2021;271(4):767–773.
   PubMed Web of Science ®Google Scholar
• Uchida Y, Sumiya T, Tachikawa M, et al. Involvement of claudin-11 in disruption of Blood-Brain, -Spinal cord, and -Arachnoid barriers in multiple sclerosis. Mol Neurobiol. 2019;56(3):2039–2056.
   PubMed Web of Science ®Google Scholar
• Vojdani A, Vojdani E, Kharrazian D. Fluctuation of zonulin levels in blood vs stability of antibodies. World J Gastroenterol. 2017;23(31):5669–5679.
   PubMed Web of Science ®Google Scholar
• Cai HQ, Catts VS, Webster MJ, et al. Increased macrophages and changed brain endothelial cell gene expression in the frontal cortex of people with schizophrenia displaying inflammation. Mol Psychiatry. 2020;25(4):761–775.
   PubMed Web of Science ®Google Scholar
• Maes M, Sirivichayakul S, Kanchanatawan B, et al. Upregulation of the ıntestinal paracellular pathway with breakdown of tight and adherens junctions in deficit schizophrenia. Mol Neurobiol. 2019;56(10):7056–7073.
   PubMed Web of Science ®Google Scholar
• Nalbant K, Erden S, Yazar A, et al. Investigation of the relation between epithelial barrier function and autism symptom severity in children with autism spectrum disorder. J Mol Neurosci. 2022;72(4):741–747.
   PubMed Web of Science ®Google Scholar
• Ma X, Hammes SR. Paxillin actions in the nucleus. Steroids. 2018;133:87–92.
   PubMed Web of Science ®Google Scholar
• Gilman SR, Iossifov I, Levy D, et al. Rare de novo variants associated with autism ımplicate a large functional network of genes ınvolved in formation and function of synapses. Neuron. 2011;70(5):898–907.
   PubMed Web of Science ®Google Scholar
• Santos R, Linker SB, Stern S, et al. Deficient LEF1 expression is associated with lithium resistance and hyperexcitability in neurons derived from bipolar disorder patients. Mol Psychiatry. 2021;26(6):2440–2456.
   PubMed Web of Science ®Google Scholar
• Urakami S, Shiina H, Enokida H, et al. Epigenetic ınactivation of wnt ınhibitory factor-1 plays an ımportant role in bladder cancer through aberrant canonical wnt/β-Catenin signaling pathway. Clin Cancer Res. 2006;12(2):383–391.
   PubMed Web of Science ®Google Scholar
• Zhang C, Li B. The correlation between LncRNA-17A expression in peripheral blood mononuclear cells and wnt/β-catenin signaling pathway and cognitive function in patients with alzheimer disease. Am J Transl Res. 2021;13(10):11981–11986.
   PubMed Web of Science ®Google Scholar
• Alexander JM, Pirone A, Jacob MH. Excessive β-Catenin in excitatory neurons results in reduced social and ıncreased repetitive behaviors and altered expression of multiple genes linked to human autism. Front Synaptic Neurosci. 2020;12:14.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association 2013. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington, VA.
   Google Scholar
• Krug DA, Arick J, Almond P. Behavior checklist for identifying severely handicapped individuals with high levels of autistic behavior. J Child Psychol Psychiatry. 1980;21(3):221–229.
   PubMed Web of Science ®Google Scholar
• Schopler E, Reichler RJ, DeVellis RF, et al. Toward objective classification of childhood autism: childhood autism rating scale (CARS). J Autism Dev Disord. 1980;10(1):91–103.
   PubMed Web of Science ®Google Scholar
• Sucuoglu B, Akkok F, Gokler B. A study about childhood autism scales. Psychiatry Psychol Psychopharmacol J. 1996;4:116–121.
   Google Scholar
• Yilmaz-Irmak T, Aydin A, Sorias O. An investigation of validity and reliability of autism behavior checklist (ABC). Turkish J Child Adolesc Ment Heal. 2007;14:13–23.
   Google Scholar
• Vuong HE, Hsiao EY. Emerging roles for the gut microbiome in autism spectrum disorder. Biol Psychiatry. 2017;81(5):411–423.
   PubMed Web of Science ®Google Scholar
• Mccullumsmıth R, Gupta D, Beneyto M, et al. Expression of transcripts for myelination-related genes in the anterior cingulate cortex in schizophrenia. Schizophr Res. 2007;90(1-3):15–27.
   PubMed Web of Science ®Google Scholar
• Maheras KJ, Peppi M, Ghoddoussi F, et al. Absence of claudin 11 in CNS myelin perturbs behavior and neurotransmitter levels in mice. Sci Rep. 2018;8(1):3798.
   PubMedGoogle Scholar
• Maier-Begandt D, Comstra HS, Molina SA, et al. A venous-specific purinergic signaling Cascade initiated by pannexin 1 regulates TNFα-induced increases in endothelial permeability. Sci Signal. 2021;14(672):eaba2940.
   PubMed Web of Science ®Google Scholar
• Wang J, Zheng B, Zhou D, et al. Supplementation of diet With different n-3/n-6 PUFA ratios ameliorates autistic behavior, reduces serotonin, and ımproves ıntestinal barrier ımpairments in a valproic acid rat model of autism. Front Psychiatry. 2020;11:552345.
   PubMed Web of Science ®Google Scholar
• Zhou Z, Bian C, Luo Z, et al. Progesterone decreases gut permeability through upregulating occludin expression in primary human gut tissues and caco-2 cells. Sci Rep. 2019;9(1):8367.
   PubMed Web of Science ®Google Scholar
• Bendriem RM, Singh S, Aleem AA, et al. Tight junction protein occludin regulates progenitor Self-Renewal and survival in developing cortex. Elife. 2019;8:e49376.
   PubMed Web of Science ®Google Scholar
• Krumm N, O'Roak BJ, Shendure J, et al. A de novo convergence of autism genetics and molecular neuroscience. Trends Neurosci. 2014;37(2):95–105.
   PubMed Web of Science ®Google Scholar
• Krupp DR, Barnard RA, Duffourd Y, et al. Exonic mosaic mutations contribute risk for autism spectrum disorder. Am J Hum Genet. 2017;101(3):369–390.
   PubMed Web of Science ®Google Scholar
• Vallée A, Vallée J-N, Lecarpentier Y. PPARγ agonists: potential treatment for autism spectrum disorder by inhibiting the canonical WNT/β-catenin pathway. Mol Psychiatry. 2019;24(5):643–652.
   PubMed Web of Science ®Google Scholar